Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Androgenetic alopecia significantly affects mental health and quality of life, highlighting the need for psychiatric evaluations.

Combining microneedling with light therapy increased hair density by 26% in men.

Dr. Bernard Cohen created a new system to classify hair loss using numbers and a detailed scalp map.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Ketoconazole lotion can improve hair regrowth for some people with androgenetic alopecia.

Balding people may have higher heart disease risk.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Hair loss in men treated best with early medication or transplant, new treatments researched.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Environmental factors like smoking, UV exposure, and poor diet contribute to hair loss and graying, and lifestyle changes can help manage it.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Male Androgenetic Alopecia, a common hair loss in men, can be slowed and partially restored with treatments like minoxidil and finasteride, or hair transplantation. Serenoa repens may be an alternative treatment. More research is needed for new treatments.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Up to 10% of hair loss patients might have early signs of a condition called Lichen Planopilaris.

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.

Hair transplantation has evolved to refined techniques like FUE and FUT, with Finasteride and Minoxidil as the only other proven treatments for hair loss.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Hair loss from genetics and hormones can be treated with drugs or surgery.

The authors suggest using a standard system to name hair grafts to improve communication in hair restoration.

Hair restoration surgery has evolved over time, with a focus on natural-looking results and managing patient expectations, while also considering potential complications and the lifelong progression of male pattern baldness.